Patents
Patents for C07C 255 - Carboxylic acid nitriles (27,066)
01/2005
01/27/2005US20050020584 Benzamide derivatives as antagonists of orexin receptors
01/27/2005US20050020544 Using pinene compound; prevention, therapy of autoimmune disease; antiarthritic agents; multiple sclerosis; lupus; antidiabetic agents; psoriasis; antihistamines; cardiovascular disorders; analgesics
01/27/2005US20050020439 Catalyst comprising cyclic acylurea compounds and processes for production organic compounds with the same
01/27/2005DE10331211A1 Verfahren zur Herstellung von 4-Cyano-3-hydroxybuttersäureestern A process for the preparation of 4-cyano-3-hydroxybutyric
01/26/2005EP1500641A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same
01/26/2005EP1499898A2 Regulation of tnf-alpha
01/26/2005EP1180095A4 4-cyano-3-hydroxy butanoyl hydrazines, derivatives and process for the preparation thereof
01/26/2005EP0970947B1 Process for producing butyric ester derivatives
01/26/2005CN1571763A Fluorene compound and organic lumnescent device using the same
01/26/2005CN1186316C Bis-dicyano-methylene-cyclohexane-ester derivatives and their synthesizing process
01/25/2005US6846958 Synthesis of benzimidate from benzoic acid
01/25/2005US6846946 Process for making organic products and improving the quality of non-product streams using phase transfer catalysis
01/25/2005US6846945 Using reaction product of Group 8 metal, phosphite and ligand as catalyst
01/25/2005US6846939 Minocycline compound substitued at 9-position by a group selected from nitro, alkyl, alkenyl, alkynyl, aryl, alkoxy, alkylthio, alkylsufinyl, alkylsulfonyl, amino, thionitroso, arylalkynyl or carbamate, urea, and sulfonamide
01/25/2005US6846492 Microbiocides; preservatives; antiseptics
01/25/2005CA2131683C Stilbene derivatives and pharmaceutical compositions containing them
01/20/2005WO2005005375A1 Method for producing 4-cyano-3-hydroxybutyric acid esters
01/20/2005WO2005004803A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
01/20/2005WO2005004802A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
01/20/2005WO2004078692A8 New bicyclo compound, method for producing fused aromatic compound using the same and method for forming film of the same
01/20/2005US20050014966 Reacting 5-bromo-(3-hydroxymethyl)benzoic acid with manganese dioxide, to form 5-bromo-3-formylbenzoic acid, then with 3-cyanophenylboronic acid, to form carbocyclic carboxy nitriles used as chemical intermediates for anticoagulants
01/20/2005US20050014944 Process for producing a nitrile compound
01/20/2005US20050014727 Antiinflammatoy agents; antiallergens; antiproliferative agents; skin disorders; viral disorders; Alzheimer's disease; muscular disorders; antiarthritic agents
01/20/2005US20050014721 reacting oxabenzonorbornadiene with nucleophiles;in presence of rhodium complex catalyst forming 2-pyrrolidin-1-ol-1,2-dihydronaphthalen-1-ol; drug used as analgesics, Parkinson's disease, anticancer agents; aids
01/20/2005CA2530006A1 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
01/20/2005CA2529994A1 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
01/19/2005EP1498406A1 Novel hydronaphthalene compounds, prepared by a rhodium catalysed ring opening reaction in the presence of phosphine ligand
01/19/2005EP1497299A2 Cross-metathesis of olefins directly substituted with an electron-withdrawing group using transition metal carbene catalysts
01/19/2005EP1497261A1 Phenethanolamine derivatives
01/19/2005EP1496838A2 Substituted amides
01/19/2005CN1568226A Phosphonites
01/19/2005CN1568225A Phosphinites
01/19/2005CN1568223A Method for producing ammoxidation catalyst
01/19/2005CN1566351A Process for producing optically active 2-[6-(hydroxymethyl)-1, 3-dioxan-4-yl]acetic acid derivatives
01/19/2005CN1566082A Microwave radiation ketone-nitrile condensation method adopting amine acetate catalysis
01/19/2005CN1566081A Methods for producing unsaturated nitriles
01/19/2005CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines
01/19/2005CN1185205C Iron-based catalyst for hydrogenating alpha, omega-dinitriles
01/18/2005US6844463 Method for the carbonylation of pentenoic acid and its derivatives thereof
01/18/2005US6844448 Main-group metal-based asymmetric catalysts and applications thereof
01/13/2005WO2005003094A1 Diarylmethyl derivatives as potassium channel modulators
01/13/2005WO2005003063A2 Process for removal of acrolein from acrylonitrile product streams
01/13/2005US20050010060 Novel quinones as disease therapies
01/13/2005US20050009816 Potassium channel modulators
01/13/2005US20050009706 Herbicides; plant safening agents
01/12/2005EP1494999A1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer
01/12/2005EP1494995A1 3-aminophenol derivatives substituted in the 2-position, and dyes containing these compounds
01/12/2005EP1494991A1 Analogous compounds of strobilurines and their use as acaricides and insecticides
01/12/2005EP0930286B1 Liquid-crystal alkenyltolan derivative, liquid-crystal composition, and liquid-crystal display element
01/12/2005CN1564809A Organic compounds
01/12/2005CN1564808A Aminonitrile production
01/12/2005CN1564807A Method of producing nitrile compounds
01/12/2005CN1564806A Processes for the production of alpha-difluoromethyl ornithine (DFMO)
01/12/2005CN1184371C Mixtures of fluorescent whitening agents
01/12/2005CN1184207C Process for producing insecticide intermediate
01/12/2005CN1184206C Prepn process of pyrazole derivative
01/11/2005US6841703 Polymerization of ethylenically unsaturated monomers with low dispersity
01/11/2005US6841699 Recalcined catalyst
01/11/2005US6841507 Aminonitrile production
01/06/2005WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/06/2005WO2005000800A1 Cathepsin cysteine protease inhibitors
01/06/2005WO2005000796A1 Amides and method for plant disease control with the same
01/06/2005WO2005000795A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
01/06/2005WO2005000794A1 Propionamide derivatives useful as androgen receptor modulators
01/06/2005WO2005000789A1 2-amino-3-alkoxybicyclo[3.1.0]hexane derivative
01/06/2005WO2005000463A2 Mixed metal oxide catalysts for propane and isobutane oxidation and ammoxidation, and methods of preparing same
01/06/2005US20050004389 Insecticides; miticides
01/06/2005US20050004388 reacting a carbonyl compound with nitrile in presence of a ligand and metal compound
01/06/2005US20050004379 Chemical intermediates for drugs; neurological disorders; psychological disorders
01/06/2005US20050004212 Antitumor/cancer activity; topoisomerase I inhibitors
01/06/2005US20050004211 Inhibiting topoisomerase I; blocking S or G2/M phase of tumor and/or cancer cells
01/06/2005US20050004192 Inhibiting virus's own RNA-dependent RNA polymerase, NS5B
01/06/2005US20050004184 Such as 3,5-Dibromo-4-(4-hydroxy-3-phenethylcarbamoyl-phenoxy)-phenyl acetic acid; metabolism regulation agents; avoiding cardiovascular and other toxicities of hormones
01/06/2005US20050004164 2-Cyanopropanoic acid amide and ester derivatives and methods of their use
01/06/2005US20050003230 cyclized; organic light-emitting diodes (OLED); eliminate drawbacks of Alq3 as emitter and a host material for dopants; narrower emission bands; broad spectral range; low driver voltages; high photometric efficiency (low power consumption); high luminance (emission intensity); high thermal stability
01/06/2005US20050002837 Reactor apparatus
01/06/2005CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/06/2005CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/06/2005CA2530068A1 Cyanoalklamino derivatives useful as cathepsin cysteine protease inhibitors
01/06/2005CA2529086A1 Process for the preparation of cinnamaldehyde compounds
01/06/2005CA2526057A1 Mixed metal oxide catalysts for propane and isobutane oxidation and ammoxidation, and methods of preparing same
01/05/2005EP1493744A1 Tropane analogs and methods for inhibition of monoamine transport
01/05/2005EP1493731A1 N-benzyl-p-phenylenediamine-derivatives containing colouring agents for keratin fibres and these derivatives
01/05/2005EP1492762A1 Photostable cationic organic sunscreen compounds with antioxidant properties and compisitions obtained therefrom
01/05/2005EP1492757A1 (2-((2-alkoxy)-phenyl)-cyclopent-1-enyl) aromatic carbo- and heterocyclic carboxylic acid and derivatives
01/05/2005EP1492745A2 Process for making organic products or non-product streams using phase transfer catalysis
01/05/2005EP0996619B1 Tropane analogs and methods for inhibition of monoamine transport
01/05/2005CN1561260A Method for the production of isophorondiamine (IPDA, 3-aminomethyl-3, 5, 5-trimethylcyclohexylamine)
01/05/2005CN1560029A Substituting Cis-1, 2-dicyano vinyl and synthesis process thereof
01/05/2005CN1183104C Treatment of ntiriles with glycolic acid
01/05/2005CN1183103C Method for producing cyanoacetic acid esters
01/05/2005CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
01/05/2005CN1183092C Intermediates and process for producing fluorine-contg. amino acid compound by using same
01/04/2005US6838466 Compounds for the treatment of inflammatory disorders
12/2004
12/30/2004US20040267054 Process for removal of acrolein from acrylonitrile product streams
12/30/2004US20040267011 Methods for synthesis of diarylmethanes
12/30/2004US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof
12/30/2004US20040266867 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis
12/30/2004US20040266798 intermediates in the preparation of derivatives which possess anti-cancer activity; synthesis of 4{N-[(6RS)-2-Methyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclopenta[g]quinazolin-6-yl]-N-(prop-2-ynyl)amino}benzoic acid
12/30/2004US20040266644 Ammonium nitriles and the use thereof as hydrophobic bleaching activators